title: [Dizziness as a side effect of pharmacological therapy].
abstract: Dizziness is a well-known side effect of a wide range of drugs. However, the side effects reported in the summary of product characteristics are not exclusively based on placebo-controlled trials. Based on a systematic review of the literature including randomised placebo-controlled clinical trials, antihypertensive combination drugs, methylphenidate, high doses of tramadol and serotonin-norepinephrine reuptake inhibitors were associated with an increased risk of dizziness. Antihypertensive monotherapy and selective serotonin reuptake inhibitors were generally not associated with an increased risk of dizziness when compared with placebo.
authors.affiliation: Klinisk Farmakologisk Afdeling, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 København NV. nanna.borup.johansen@regionh.dk.
authors.forename: Nanna
authors.initials: N
authors.lastname: Borup Johansen
authors.forename: Mahnaz
authors.initials: M
authors.lastname: Ayadipanah
authors.forename: Emilie Sofia
authors.initials: ES
authors.lastname: Sonnenschein
authors.forename: Hanne Rolighed
authors.initials: HR
authors.lastname: Christensen
authors.forename: Gesche
authors.initials: G
authors.lastname: Jürgens
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D004244:Dizziness / Q000139:chemically induced*; D004347:Drug Interactions; D004348:Drug Labeling / Q000706:statistics & numerical data; D064420:Drug-Related Side Effects and Adverse Reactions / Q000150:complications*; D006801:Humans
chemical_list: D000928:Antidepressive Agents; D000959:Antihypertensive Agents